Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

Go back to Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.65 -0.06 (1.62%)
Previous Close $3.71    52 Week High $24.68 
Open $3.61    52 Week Low $9.10 
Day High $3.66    P/E N/A 
Day Low $3.58    EPS $0.00 
Volume 1,984,753       

Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 140.33 -5.22 (3.59%)
Previous Close $145.55    52 Week High $0.52 
Open $145.98    52 Week Low $0.08 
Day High $147.50    P/E N/A 
Day Low $139.70    EPS $-3.80 
Volume 10,304,047